Silence Therapeutics SLN
NASDAQ SLN
$19.77 -0.02 (-0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Silence Therapeutics (SLN) Cash & Current Investments (2018 - 2026)

Updated

Silence Therapeutics' Cash & Current Investments was $72.1 million in the quarter ended Jun 30, 2026, down 36.9% from $114.2 million a year earlier but up 2.9% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Cash & Current Investments (2018 - 2026) Analysis & Trends

As of Dec 31, 2025, Cash & Current Investments at Silence Therapeutics came in at $85.1 million, down 42.2% from the prior year.

  • Cash & Current Investments shows a five-year compound annual growth rate of 19.3% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Cash & Current Investments was $147.3 million in the year ended Dec 31, 2024 (+119.7%), $67.06 million in the year ended Dec 31, 2023 (-1.1%), $67.84 million in the year ended Dec 31, 2022 (-32.9%) and $101.18 million in the year ended Dec 31, 2021 (+187.0%).
  • Quarterly Cash & Current Investments has moved between $64.3 million (the quarter ended Dec 31, 2022) and $147.3 million (the quarter ended Dec 31, 2024) over five years.
  • Compared with a year earlier, Cash & Current Investments has declined for three straight quarters, with an average decline of 2.0% over the last four quarters.
  • Per Business Quant data, SLN's Cash & Current Investments in the three quarters before the quarter ended Jun 30, 2026 was $70.1 million (quarter ended Mar 31, 2026), $85.1 million (quarter ended Dec 31, 2025) and $102.2 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Silence Therapeutics 935.01 Mn 862.91 Mn - 72.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.10 Mn
Mar 31, 2026 70.10 Mn
Dec 31, 2025 85.10 Mn
Sep 30, 2025 102.20 Mn
Jun 30, 2025 114.20 Mn
Mar 31, 2025 136.50 Mn
Dec 31, 2024 147.30 Mn
Sep 30, 2024 83.29 Mn
Jun 30, 2024 138.81 Mn
Mar 31, 2024 143.11 Mn
Dec 31, 2023 105.77 Mn
Sep 30, 2023 72.13 Mn
Jun 30, 2023 37.85 Mn
Mar 31, 2023 58.24 Mn
Dec 31, 2022 19.75 Bn
Sep 30, 2022 100.86 Mn
Jun 30, 2022 62.93 Mn
Mar 31, 2022 78.30 Mn
Dec 31, 2021 99.67 Mn
Sep 30, 2021 96.36 Mn
API Access

Silence Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SLN&period=max&api_key=YOUR_API_KEY